Zobrazeno 1 - 10
of 44
pro vyhledávání: '"W O, Böcher"'
Autor:
K. Stein, Dietrich Hüppe, Heiner Wedemeyer, Christoph Sarrazin, Bernd Möller, Bertram Wiedenmann, Heinz-Hubert Feucht, Robert A. de Man, Jurrien G.P. Reinders, Jörg Petersen, Jörg Trojan, W. O. Böcher, Florian van Bömmel, Katja Deterding, Peter Buggisch, Hermann E. Wasmuth, Peter Rhode, Andreas Erhardt, Thomas Berg, Ulrich Spengler
Publikováno v:
Hepatology, 51(1), 73-80. John Wiley & Sons Ltd.
Tenofovir disoproxil fumarate (TDF) has demonstrated high antiviral efficacy in treatment-naive patients with chronic hepatitis B virus (HBV) infection but experience in nucleoside/nucleotide analogue (NA)-experienced patients is limited. In this ret
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae83b714aec57f66c8d15fa263c38b7d
https://doi.org/10.1002/hep.23246
https://doi.org/10.1002/hep.23246
Publikováno v:
Liver International. 28:347-354
Background/Aims: In vitro studies in the subgenomic hepatitis C virus (HCV) replicon system have identified all-trans retinoic acid (ATRA) as a potential therapeutic against hepatitis C. Thus, the antiviral potential of this drug should be assessed i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d318adb691918bfc06c572c06149c8ee
https://doi.org/10.1111/j.1478-3231.2007.01666.x
https://doi.org/10.1111/j.1478-3231.2007.01666.x
Autor:
Dieter Glebe, S. Grün, D. Strand, I. Mederacke, Soheila Tavakoli, W. O. Böcher, Adam J. Gehring, Stephan Urban, Peter R. Galle, S. Herzog-Hauff
Publikováno v:
Clinical and Experimental Immunology. 151:61-70
Summary Persistence of hepatitis B virus (HBV) infection is associated with reduced anti-viral T cell responses. Impaired dendritic cell (DC) function was suggested as the cause of reduced T cell stimulation in chronic HBV carriers. Thus, we compared
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::501b94b0b7207cd906e25867a95a30d6
https://doi.org/10.1111/j.1365-2249.2007.03547.x
https://doi.org/10.1111/j.1365-2249.2007.03547.x
Autor:
PR Galle, Gerd Otto, AW Lohse, AP Barreiros, J. Thies, E.M. Bayer, G. Greif-Higer, Stephan Kanzler, Christian Mönch, W. O. Böcher, M Wunsch, M. Schuchmann
Publikováno v:
Zeitschrift für Gastroenterologie. 41
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3d8cb5231f752a84fd9f1ae5f6188b4a
https://doi.org/10.1055/s-0035-1555409
https://doi.org/10.1055/s-0035-1555409
Autor:
Hildegard Spahn-Langguth, W. O. Böcher, Peter Langguth, Daniel Wagner, Christine Weiler, R. Wanitschke, Marija Tubic
Publikováno v:
European Journal of Pharmaceutical Sciences. 29:231-239
Objective The number of active pharmaceutical ingredients (API) undergoing inhibitable and saturable intestinal efflux is considerable. As a consequence, absorption and bioavailability may depend on the intestinal concentration profile of the drug an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be4b3b57bb226beac0a89fbbd9618367
https://doi.org/10.1016/j.ejps.2006.04.005
https://doi.org/10.1016/j.ejps.2006.04.005
Autor:
Daniel Lavanchy, W. O. Böcher, Brian J. McMahon, Guido François, Ulus Salih Akarca, David FitzSimons, Wolfgang Jilg, Susan Goldstein, Andrew J. Hall, Bernard Duval, J. E. Banatvala, Alessandro Zanetti, André Meheus, Pierre Van Damme, Sheng-Nan Lu
Publikováno v:
Vaccine
The long-term efficacy of hepatitis B vaccine, long-term effectiveness of hepatitis B immunisation programmes, immune memory induced by hepatitis B vaccine, current booster policies, and impact of hepatitis B virus mutants on immunisation programmes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c45b4eb5709d15709465d915098c3fcd
https://doi.org/10.1016/j.vaccine.2005.03.017
https://doi.org/10.1016/j.vaccine.2005.03.017
Autor:
Thomas Hoehler, W. O. Böcher, P. Adams, Peter M. Schneider, A. Kruger, Christian Rittner, J. Hammer
Publikováno v:
Clinical and Experimental Immunology. 140:325-332
Summary The aim of this study was to investigate the underlying mechanisms of the genetic association between certain HLA-DRB1* alleles and the immune response to HBsAg vaccination. Therefore, HBsAg peptide binding to HLA-DR molecules was measured in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6bb7fab7bec58703fedfb25164fcb0e
https://doi.org/10.1111/j.1365-2249.2005.02765.x
https://doi.org/10.1111/j.1365-2249.2005.02765.x
Publikováno v:
Journal of Medical Virology. 66:452-460
To evaluate therapeutic immunostimulation nine chronic hepatitis B patients received six monthly intradermal vaccinations with HBsAg in combination with daily lamivudine. Another five patients received six doses of the vaccine and daily lamivudine to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a78c5b2e93333faf76277a00fe9c4f54
https://doi.org/10.1002/jmv.2165
https://doi.org/10.1002/jmv.2165
Publikováno v:
Hepatology. 31:521-527
The vaccination route may influence the success of immunization against pathogens. The conventional intramuscular (i.m.) application of a vaccine containing the hepatitis B virus (HBV) surface antigen (HBsAg) led to protective anti-HBs antibody level
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d99910f882c83247deadab054109e34
https://doi.org/10.1002/hep.510310237
https://doi.org/10.1002/hep.510310237
Autor:
S. Herzog-Hauff, W. O. Böcher, Karl-Hermann Meyer zum Büschenfelde, Hanns Friedrich Löhr, Jörg F. Schlaak
Publikováno v:
Hepatology. 29:238-244
Because cellular and humoral immune responses against the hepatitis B virus (HBV) surface antigen (HBs) might be crucial to overcome HBV infection, HBs-specific B- and T-cell responses of HBV patients and HBs vaccine recipients were analyzed quantita
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::368a70cb8220662ce7d899961ed6772e
https://doi.org/10.1002/hep.510290120
https://doi.org/10.1002/hep.510290120